Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.
Papp R, Nagaraj C, Zabini D, Nagy BM, Lengyel M, Skofic Maurer D, Sharma N, Egemnazarov B, Kovacs G, Kwapiszewska G, Marsh LM, Hrzenjak A, Höfler G, Didiasova M, Wygrecka M, Sievers LK, Szucs P, Enyedi P, Ghanim B, Klepetko W, Olschewski H, Olschewski A.
Papp R, et al. Among authors: ghanim b.
Eur Respir J. 2019 Jun 5;53(6):1800965. doi: 10.1183/13993003.00965-2018. Print 2019 Jun.
Eur Respir J. 2019.
PMID: 31023847
Free article.